Pharmaceutical industry may collapse under KORUS FTA.

The Korea and U. S. FTA system may accelerate the domestic drug industry substantially to transform stemming from which the original branded drugs supplied by most of foreign multinational drug corporations may predominate whole Korean pharmaceutical markets.

Dr. Lee Ui-gyeong of Korea Institute for Health and Social Affairs (KIHSA) said as described above in the briefing of "the KORUS FTA p...